Livzon Pharmaceutical Group Inc. (SZSE:000513) entered into share purchase agreement to acquire an additional 3% stake in Zhuhai Livzon Diagnostics Inc. from Li Lin for CNY 24.57 million on November 17, 2023. In related transaction Livzon Pharmaceutical will acquire 5% stake from Shi Jianfeng. The Acquisitions will be funded by internal resources of the Company. Zhuhai Livzon Diagnostics reported Total Common equity of CNY 796.7 millions on June 30, 2023. Transaction is subject to approval from Livzon Pharmaceutical board of director's.

Livzon Pharmaceutical Group Inc. (SZSE:000513) completed the acquisition of an additional 3% stake in Zhuhai Livzon Diagnostics Inc. from Li Lin on November 21, 2023. As of November 21, 2023, the consideration has been paid.